Airbound will use the seed funds to deploy its R&D efforts and venture into medical deliveries, specifically routine deliveries such as transporting blood samples from health centres to testing labs, founder Naman Push told ET. The startup plans to go live with its product in early 2025. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
